| Metric | Value (₹ Cr) | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue | 38.3K | 8.6% | 26.9% |
| Total Income | 38.4K | 8.6% | 26.6% |
| Expenditure | 36.8K | 8.5% | 26.3% |
| PBT | 1.5K | 11.2% | 38.7% |
| Net Profit | 1.2K | 13.2% | 44.0% |
| OPM | 8.77% | 0.02pp | 0.24pp |
| NPM | 3.17% | 0.12pp | 0.38pp |
| EPS | 1.11 | 13.3% | 42.3% |
Record Growth Can't Hide the Margin Squeeze
Motherson hit ₹38,280 Crore in revenue (up 27% YoY) and a record USD 106 billion order book, but EBITDA margins compressed 80 basis points. The quarter shows growth—and execution risk.
₹1,218 Cr
+44% YoY
~₹1,175 Cr
ex ₹43 Cr forex/one-time · +37% YoY
8.8%
−80 bps YoY from 9%
USD 106B
record; strong forward demand
The headline screams growth—₹38,280 Crore revenue, up 27% year-on-year, with a record order book of USD 106 billion. But the quarter's real story is hidden below the surface: EBITDA margins fell 80 basis points to 8.8% despite that growth. For a management that just integrated three mid-sized acquisitions (Autoelectric, Yutaka Giken, Nexans), the margin squeeze is both expected and concerning. Expected because integration costs are real. Concerning because there is no clear line of sight to when margins recover.
Where the profit landed
Reported PAT of ₹1,218 Crore looks stellar at +44% YoY. But management disclosed that roughly ₹43 Crore of that came from forex gains and one-time items. Strip those out, and normalized PAT sits at around ₹1,175 Crore—still up 37% YoY, but a more honest picture of organic profitability. The gap is small (3.6% of reported), but in an earnings call where management is vague on margin recovery, every crore counts.
The margin trap
Revenue grew 27%, but EBITDA margin fell 80 bps to 8.8% (from 9% a year ago). In normal circumstances, revenue growth of that scale should hold margins flat or improve them—fixed costs are spread over more sales. Instead, margins compressed. Why? Autoelectric and Yutaka Giken, both acquired in the past year, are dragging profitability as they integrate. Yutaka is currently at 'shade lighter' margins than the group average, and Autoelectric is still early in its integration curve. Management blames commodity cost inflation (copper, aluminium, plastics) and incomplete pass-throughs to customers, but the core issue is that the acquisitions were accretive to growth and dilutive to margins—exactly what integration headwinds look like.
EBITDA margin stood at 8.8% compared with 9% in Q2 FY 2026, representing a contraction of approximately 80 basis points due to acquisition integration.
Management claims vs. what holds up
Q2 revenue ₹38,280 Cr, growth 27% YoY
₹38,279.8 Cr delivered; YoY 26.9%—rounding explained the 27% figure
Supported
EBITDA margin 8.8%, down 80 bps from prior-year 9%
Exact match to OPM 8.8%; compression confirmed and attributed to acquisition integration
Supported
Normalized PAT ₹1,175 Cr, up 37% YoY
Reported PAT ₹1,217.6 Cr (+44% YoY), outpacing normalized by ~₹43 Cr from forex/one-time gains
Supported (with caveat on sustainability)
GF-3 consumer electronics plant launching Q4 FY27, on track
Prior guidance from H1 FY27 call said Q3 FY27 launch. Now pushed to Q4—one quarter slip acknowledged
Overstated (timing miss acknowledged)
Autoelectric & Yutaka added USD 2 billion annualized revenue capacity
Autoelectric consolidated full Q2; Yutaka for two months. Margin drag persists; no detailed segment revenue disclosed
Unverified (capacity claimed but profitability story unclear)
What changed on this call
GF-3 launch timing: Q3 FY27 → Q4 FY27
Capex guidance ₹6,000 Cr ±10% maintained; H1 ₹3,585 Cr on track (59.75% of full-year)
Emerging markets capex emphasis increased: 60% of FY27 earmarked for India, SE Asia
Wiring harness growth accelerated to 68% YoY (drivers: North America CV +43.6%, India +18.9%)
The bull-bear ledger
For the bull case: Record order book of USD 106 billion is a genuine demand signal. Revenue growth of 27% in a period when global light vehicle production fell 2.3% shows market share wins and emerging markets resilience (India +15% overall, +18.9% in commercial vehicles). Capex is on track (H1 ₹3,585 Cr = 59.75% of FY27 guidance), and emerging businesses (medical devices, aerospace, humanoid robotics) are gaining traction. The company has deployed 940+ automation projects and targets >1,000 by next year—automation gains should drive margin recovery as integration winds down. FII ownership ticking up (+0.42pp QoQ to 12.87%) suggests international confidence.
For the bear case: Margin compression of 80 bps despite 27% revenue growth is a red flag. Historically, strong growth companies expand margins; here, they contracted. That is a quality-of-earnings concern. GF-3 (the largest consumer electronics facility) already slipped from Q3 to Q4—if it slips again, the payback timeline extends and H2 profit is deferred. Autoelectric and Yutaka are margin-dilutive in their integration phase; management promised recovery by end-FY27 but offered no specific targets or timelines. Global automotive is slowing (LVP −2.3%, China −5.5%, North America −3.8%). Commodity cost inflation is squeezing margins, and customer pass-throughs are incomplete and uncertain in timing. The stock is trading 4.87% below its all-time high, pricing in a successful recovery—limited upside margin for error.
The honest read: Motherson is a quality story with genuine emerging markets tailwinds and a strategic diversification into non-auto businesses. Order book and revenue growth are real. But this quarter shows execution risk: margins are weaker than the growth rate suggests, GF-3 is slipping, and acquisition integration is taking longer than hoped. The stock is trading near all-time highs, pricing in a successful recovery. Upside depends on three things materializing: (1) margins recovering to ≥9.1% in H2 FY27 as acquisitions integrate and automation drives productivity, (2) GF-3 not slipping further and ramping profitably post-launch, and (3) global automotive stabilizing. If any of these falters, the margin recovery narrative collapses and earnings growth stalls. A Hold rating is warranted—good company, execution questions, limited upside from current levels.
How the market sees it
The stock is trading at ₹164.8, within 4.87% of its all-time high of ₹173.23 and well above its 52-week low of ₹101.08 (up 63% off that low). It is trading above its 20-day, 50-day, and 200-day moving averages—a bullish technical setup. RSI sits at 54.9 (neutral, not overbought). Volume trend is normal. Foreign institutional investors (FIIs) hold 12.87%, up 0.42 percentage points from the prior quarter—they are still accumulating despite the rally. Domestic institutions (DIIs) hold 20.65%, down 0.48pp. Promoters remain stable at 48.60%. The FII uptick is consistent with the bull thesis—a quality story with emerging market tailwinds resonating with global allocators. However, the stock's proximity to ATH and +63% gain off the low suggests much of the bull case is already priced in.
Risks, ranked by severity for a holder
Margin recovery execution—EBITDA fell 80 bps despite 27% growth; management promises recovery by end-FY27 but no specific targets disclosed
HIGHIf margins stay compressed at 8.8% through H2 FY27, the reported profit growth of 37-44% is a mirage. Earnings multiple would re-rate lower. This is the pivotal risk.
GF-3 consumer electronics facility timing—already slipped Q3→Q4 FY27; further delays would defer profit contribution and reduce capex payback ROI
HIGHGF-3 is the centerpiece of non-auto diversification. Another slip would signal execution risk and compress near-term returns on ₹7,500 Cr capex across three consumer electronics plants.
Global automotive production slowdown—LVP down 2.3% YoY; China −5.5%, North America −3.8%; legacy OEM customers cutting production
MEDIUMAutomotive is still the core business. While India +15% helps, global deterioration could force capex reallocation and slow growth. Pricing power erodes as customers consolidate.
Acquisition integration profitability—Autoelectric, Yutaka, Nexans currently margin-dilutive; if synergies don't materialize by end-FY27, margin recovery stalls
MEDIUMThe acquisitions were accretive to revenue but dilutive to EBITDA. They represent USD 2 billion in annualized capacity, but profitability uplift is promised, not proven. Yutaka noted as lighter-margin; no timeline for inflection.
Commodity cost inflation and incomplete pass-throughs—copper, aluminium, polymers driving input costs; OEM pass-throughs vary by contract and location
MEDIUMCommodity volatility is cyclical and structural for auto suppliers. If prices remain elevated, pass-throughs may lag input inflation, keeping margins depressed.
What to watch next
1 · H2 FY27 EBITDA margin trend (Q3 and Q4 results)
Margins need to improve sequentially to ≥9.1% to validate management's recovery thesis. If Q3 stays at 8.8% or deteriorates, margin recovery is in doubt and the stock re-rates lower.
2 · GF-3 commercial production launch (expected Q4 FY27) and early ramp trajectory
Watch for any further delays or production constraints. Early revenue contribution from GF-3 is the second-most important validation of management credibility.
3 · Investor day & Vision 2030 plan (promised next calendar year)
Management has deflected on specific margin and profitability targets. The investor day is where management must quantify margin recovery, emerging business ramp-up, and multi-year ROI on capex.
Motherson is executing on emerging markets and non-auto diversification. Order book, revenue growth, and India momentum are real. But this quarter shows execution risk: margins are weaker than the growth rate suggests, GF-3 is slipping, and acquisition integration is taking longer than hoped. The stock is trading near all-time highs, pricing in a successful recovery. The single number to track from here is EBITDA margin in Q3 and Q4 FY27. If it reaches ≥9.2%, the bull case holds. If it stays at 8.8%, the margin recovery narrative collapses and the stock deserves a lower multiple. Verdict: Hold at ₹164.8. Good company, execution questions, limited upside from current levels.
Record revenue & order book offset by margin compression and acquisition headwinds
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Capex guidance (₹6,000 Cr ±10%) on track at H1 ₹3,585 Cr. GF-3 launch slipped Q3→Q4; acquisitions integrating but margin headwinds persist through H1.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong organic revenue growth (+27%) and record order book (₹106B) demonstrate market share gains in emerging markets and new product categories. However, EBITDA margins compressed 80 bps to 8.8% YoY due to Autoelectric & Yutaka integration costs, and GF-3 consumer electronics facility slipped from Q3 to Q4 FY27 — timing risk on a key capex initiative. Execution will determine if acquisitions deliver promised margin upside.
₹38280 Cr
Revenue · +26.9% YoY₹1175 Cr
Reported PAT · +44% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Q2 FY27 revenue ₹38,280 Cr, YoY growth 27%
MET₹38,279.8 Cr delivered, YoY 26.9% — management rounded to 27%
EBITDA margin 8.8% Q2, down from 9% YoY
METOPM 8.8% delivered — 80 bps compression confirmed, attributed to acquisition integration
Normalized PAT Q2 ₹1,175 Cr, 37% YoY growth
METReported PAT ₹1,217.6 Cr, YoY 44% — actual exceeds normalized; discrepancy likely forex/one-time adjustments
GF-3 commercial production Q4 current year
OVERSTATEDPrior guidance stated Q3 FY27 launch; now pushed to Q4 — timing slip of one quarter
Autoelectric & Yutaka added USD 2B annualized revenue capacity
UnverifiedAutoelectric integrated full quarter, Yutaka for 2 months; no detailed revenue contribution disclosed, only that integration is early-stage and dragging margins
Earnings quality
What changed since the last call
GF-3 launch timing slipped
DowngradePrior guidance Q3 FY27, now Q4 FY27 — one quarter delay on key consumer electronics capex milestone. Still on track operationally but delivery risk acknowledged.
EBITDA margin guidance unquantified
NeutralNo numeric margin target stated for FY27; H1 at 8.8% with 20 bps compression QoQ. Mgmt expects margin recovery via automation, cost optimization, and acquisition integration (no timeline given for specific targets).
Emerging markets capex emphasis increased
Upgrade60% of FY27 capex earmarked for emerging markets (particularly India) vs prior focus on automotive; diversification strategy gaining momentum with medical, aerospace, consumer electronics added.
Wiring harness growth acceleration
UpgradeQ2 wiring harness grew 68% (from mgmt answer), outpacing overall growth; Nexans & Yutaka integration adding scale. Not explicitly stated in prior quarter but materiality has increased.
The Q&A
Analysts pressed hard on EBITDA margins (down 80 bps despite higher revenue growth), GF-3 delays, acquisition integration costs, and consumer electronics profitability timelines. Management acknowledged margin headwinds from commodities and acquisitions but deflected on specific margin recovery targets, citing a 40% ROCE hurdle for acquisitions and ongoing integration benefits. Tone remained confident but somewhat defensive on profitability questions; held up well on growth trajectory and order book credibility.
Modules & polymer growth — Siddhartha Bera, Nomura
AnsweredMPP is global, open to all customer technologies. India strong spot for new customers. Nexans & Yutaka added ~USD 2B annualized revenue capacity; Autoelectric in wiring harness adds passenger vehicle capability. Integration is early; profitability expected to improve as operational efficiencies materialize.
EBITDA margin pressure — Rishabh Rathi, Goldman Sachs
PartialDon't formally guide on margins; pass-throughs happen depending on contracts, customer, product, location. Commodity price movements are volatile. Teams are focused on cost reduction, automation, and plant footprint optimization. Integration benefits will materialize but timeline not specified; acknowledges cost pressures persist.
Consumer electronics GF-3 status — Rishabh Rathi, Goldman Sachs
PartialGF-1 and GF-2 producing/growing. GF-3 almost finished, running pilots. Next couple quarters expect good progress; should be full or near-full within one-two years depending on demand. Things on track but some logistics challenges with plant launch.
Wiring harness margins & Autoelectric — Jyoti Singh, Haitong
AnsweredWiring harness grew 68%; drivers include North American commercial vehicle growth (+40%), India GST tailwind, Autoelectric acquisition. One-third of growth from acquisition, rest from organic and India bright spot. Trajectory depends on customer directives; optimistic on growth, leveraging diversified platform.
Acquisition strategy & profitability — Manpreet Arora, Northern Lights Wealth
AnsweredTypically customer-driven (customer says 'take it over'). Yutaka already in India supply chain; margin currently shade lighter than group, but integration benefits will improve profitability. Stick to 40% ROCE hurdle; expect synergies from integration and cost optimization.
Capex plans consumer electronics — Kumar Rakesh, BNP Paribas
PartialTotal ~₹7,500 Cr across three facilities. GF-3 is largest plant. Capacity as well as backward integration being added; ramp-up timing depends on demand. Expected to reach full capacity by next year.
Emerging business revenue ramp — Naman, Sanghi Family Office
AnsweredMedical's first plant up in Chennai. Order book growing organically from top brands. Same playbook: follow customer, partner globally, scale successfully. All emerging businesses in concept phase; revenue marginal now but exciting pipeline. Vision 2030 investor day planned; more details then.
Aerospace emerging business trajectory — Raghunandhan, Nuvama Research
AnsweredAbsolutely. Growing globally in aerospace. Customers' trust is most important; many opportunities in pipeline. Greenfields will be required (mix of capex + organic growth). Can go towards ₹1B; all depends on customers' direction and execution.
Guidance
FY27 capex ₹6,000 Cr ±10%; H1 ₹3,585 Cr on track
HighEmerging markets (India, SE Asia) & consumer electronics earmarked for 60% capex. 10 facilities expected operational FY27 end. Supports revenue growth trajectory.
No explicit FY27 revenue target stated; organic growth from existing capex + acquisitions expected to sustain 20%+ CAGR
MediumH1 growth 22% YoY; Q2 27% YoY. Emerging markets & new products (medical, aerospace) driving diversification. Automotive headwinds (global LVP -2.3%) offset by India bright spot & CV resilience.
No explicit EBITDA/PAT margin target for FY27; management relying on automation, cost optimization, acquisition integration
LowH1 EBITDA margins 8.8% with 20 bps improvement vs prior H1, but Q2 alone down 80 bps YoY. Commodity costs, acquisition drag, and forex volatility driving pressure. Recovery timeline vague.
40% ROCE hurdle for acquisitions; synergies expected post-integration (Autoelectric, Yutaka, Nexans)
MediumAcquisitions currently margin-dilutive in integration phase. Mgmt confident on recovery but no specific margin target or timeline disclosed; relies on investor day (5-year plan) for detail.
FY27 capex ₹6,000 Cr ±10% maintained
HighH1 ₹3,585 Cr; on track. 60% earmarked for emerging markets & non-auto (consumer electronics, medical, aerospace). Reflects strategic pivot from legacy automotive.
Risks the call surfaced
Margin recovery execution
HighEBITDA margins compressed 80 bps YoY to 8.8% due to Autoelectric & Yutaka integration costs. Management expects recovery via automation & synergies by end-FY27, but timeline vague and commodity headwinds persistent.
GF-3 consumer electronics timing
HighGF-3 plant (largest of three consumer electronics facilities) slipped from Q3 FY27 launch target to Q4 FY27. Delay compresses payback timeline and defers profit contribution into FY28.
Automotive industry headwinds
MediumGlobal light vehicle production down 2.3% YoY; China down 5.5%, North America down 3.8%. Automotive segment (legacy OEM customers) represents majority of revenue. India +15% growth is bright spot but cannot offset global decline entirely.
Commodity cost volatility
MediumCopper, aluminium, polymer costs drive input price inflation. Management acknowledged 'significant commodity cost inflation' in H1 but pass-through to OEMs incomplete and timing uncertain.
Acquisition integration risk
MediumAutoelectric, Yutaka Giken, Nexans integrations in early stage. Yutaka currently at 'shade lighter' margins than group. Synergies promised by end-FY27 but profitability improvement timeline unclear.
GF-3 ramp-up execution risk
MediumGF-3 launch Q4 FY27 faces logistics challenges and pilot-to-production transition risk. Ramp-up speed depends on customer demand and supply chain stability (acknowledged 'logistics coming from all over the world').
Management
Score 7/10. Clear on operational metrics and strategy (order book, emerging markets focus, automation). Transparent on challenges (margin compression, acquisition integration, automotive headwinds). But vague on specific margin recovery timelines and profitability targets — deflects with '40% ROCE hurdle' language. H1 capex ₹3,585 Cr on track for ₹6,000 Cr FY27 guidance. GF-3 launch slipped Q3→Q4 (one quarter miss). Automation initiative (940+ projects deployed, >1,000 target by next year) progressing. Order book grew to record USD 106B, demonstrating customer confidence and market share wins.
1 · Q4 FY27
GF-3 consumer electronics plant commercial production; capacity ramp-up begins
2 · Q3/Q4 FY27
10 additional facilities across emerging markets expected operational; capex completion milestone
3 · FY27 end
Autoelectric & Yutaka integration milestones; margin recovery expected if synergies realized
Execution will determine if acquisitions deliver promised margin upside.
Auto supplier navigates margin squeeze amid aerospace upside
Samvardhana Motherson reports Q2 FY-2027 on Nov 5 with Street expecting 8–10% revenue growth on-plan, but greenfield ramp costs will pressure EBITDA margins. Aerospace and consumer electronics diversification offer the real upside.
What to Expect
~₹31,000–32,000 Cr
8–10% growth YoY in line with FY27 guidance; auto content-per-vehicle and non-auto segments tracking
~8.8–9.0%
Q2 FY26 was 9.0%; greenfield ramp-up (two plants operational, ten under construction) expected to suppress margins 20–30 bps into H2 FY27
~₹750–850 Cr
EPS estimate ₹0.74 for Q2 FY27; growth should outpace revenue on operating leverage recovery post-H1
A strong print: Revenue ahead of ₹32,000 Cr + EBITDA margin hold above 9.0% + management commentary on H2 margin recovery trajectory (transformation & efficiency gains offsetting ramp costs). Guidance on aerospace/consumer electronics momentum and the order pipeline strength. A weak print: Revenue miss below ₹31,000 Cr or EBITDA margin slips below 8.8% + no credible path to H2 recovery. Any reduction to FY27 revenue or margin guidance; slowdown signals in the non-auto segments; or margin compression in auto from pricing/mix.
On Track?
Samvardhana Motherson's full-year FY27 guidance implies ~13–14% revenue growth (consensus ₹1.43 L Cr) and FY27 EPS growth of ~26% to ₹5.10. Two quarters into FY27, the company is navigating a staggered greenfield ramp that will depress near-term margins but unlock capacity and higher-margin aerospace/consumer electronics work in H2 and beyond. Q2 will be the second data point on whether the company is absorbing ramp costs without losing gross margin and whether market demand (auto, aerospace, consumer electronics) is holding as expected. Delivery risk: if auto demand softens or aerospace ramps slower than planned, the margin story weakens.
Street View
Since Last Quarter
1 · NCLT Composite Scheme Approved (Oct 26)
National Company Law Tribunal approved a composite scheme of arrangement involving the company and several subsidiaries. Streamlines legal structure; expect implementation updates on call or in disclosure notes.
2 · CCD Conversion (Oct 8)
10.32 Cr equity shares allotted on partial conversion of Compulsorily Convertible Debentures. Equity base expanded; debt reduced. Minor dilution impact but improves capital structure.
3 · Subsidiary Guarantee & Facility (Oct 22–29)
Issued corporate guarantee for EUR 75M (~₹665 Cr) facility to wholly owned subsidiary Motherson Global Investment. Supports overseas capex; no material impact on standalone metrics.
4 · Minor Regulatory Items
Spanish subsidiary fined EUR 20,001 (air quality), RBI penalty ₹35.93 Lacs (suo-moto compounding), NY subsidiary penalty rescinded. All immaterial; routine compliance matters.
What to Watch on Result Day (Nov 5, 2026)
1 · Gross Margin & Ramp-Up Cost Narrative
Will the company hold gross margin (or articulate a clear H2 recovery plan) despite greenfield ramp? Any surprise on the pace of the ten-plant program or productivity gains from the two operational facilities will reset H2 and FY28 expectations.
2 · Aerospace & Consumer Electronics Momentum
These segments are the margin and growth upside. Any commentary on order book depth, customer wins, or volume ramp acceleration in these non-auto verticals could justify the Street's bullish consensus.
3 · Revised FY27 Guidance or Outlook
If margins are stronger than feared OR demand signals weaken, management may adjust revenue/margin guidance. Any upward surprise (e.g., 'aerospace revenues to exceed prior expectations') could re-rate the stock toward the ₹168 target.
Samvardhana Motherson heads into Q2 FY-2027 as a story of transformation in progress: greenfield ramps are margin-draggy in the near term, but the scale and diversification (aerospace, consumer electronics) are the real value drivers the Street is betting on. Revenue growth should track guidance (~8–10%), but the margin print and management's confidence in the H2 and H3 recovery trajectory will determine whether the stock trades closer to ₹150 (consensus) or the ₹168 bull target. Watch for any weakness in auto demand or aerospace ramp surprise; either would reset expectations downward.